Navigation Links
Mitochondrial DNA mutations play significant role in prostate cancer

Mutations in mitochondrial DNA (mtDNA) play an important role in the development of prostate cancer, according to research by scientists at Emory University School of Medicine and the University of California, Irvine. The findings are published online this week in the Proceedings of the National Academy of Sciences (PNAS). Mitochondrial DNA, which is separate from nuclear DNA, is found in the hundreds of mitochondria located in the cytoplasm outside of each cell's nucleus. The mitochondria often are called the "powerhouse" of the cell because they produce about 90 percent of the body's energy. John A. Petros, MD, associate professor of urology and pathology at Emory University School of Medicine and the Winship Cancer Institute, and Douglas C. Wallace, PhD, director of the Center for Molecular and Mitochondrial Medicine and Genetics at the University of California, Irvine, sequenced segments of mtDNA from prostate cancer patients and found a variety of mutations, including various mutations in the mtDNA cytochrome oxidase subunit (COI) gene.

They then sequenced the COI gene in 260 prostate cancer tissue samples or blood cells from patients with confirmed cancer who had undergone radical prostatectomies between 1995 and 2002, and 54 tissue samples from patients who had prostate biopsies but were found to be cancer free. Twelve percent of all the prostate cancer samples had mutations in the COI gene, while less than 2 percent of the samples from patients found to be cancer free harbored mutations in this gene. In a control sample of 1,019 individuals from the general population, 7.8 percent had mutations in the COI gene. The researchers found both germ-line (inherited) and somatic (acquired) mutations in the prostate cancer samples. Because COI mutations are known to be more common in individuals of African descent, the scientists also analyzed a group of patients and controls of European ancestry. In this group they found the COI mutations in 11 percent of th
'"/>

Source:Eurekalert


Page: 1 2

Related biology news :

1. Mitochondrial DNA sequencing tool updated
2. Mitochondrial genes move to the nucleus -- but its not for the sex
3. Novel technology detects human DNA mutations
4. Bioelectronic ‘signatures?hold key to DNA mutations
5. Multi-species genome comparison sheds new light on evolutionary processes, cancer mutations
6. DNA size a crucial factor in genetic mutations, study finds
7. New view of cancer: Epigenetic changes come before mutations
8. ASU researchers wire DNA to identify mutations
9. Carbon nanotubes that detect disease-causing mutations developed by Pitt researcher
10. Minor mutations in avian flu virus increase chances of human infection
11. New findings offer more complete view of breast cancer gene mutations in US population

Post Your Comments:
(Date:11/20/2009)...f flax shives, and generated from Brassica carina...h engulf fields in spring, can be used to produce ... carried out by Spanish and Dutch researchers and ...e Energy Reviews . , "These studies evaluate, fro...f bioethanol from two, as yet unexploited sources ...
(Date:11/20/2009)...enter (ERC) has been awarded a grant from the U.S....recovering and reusing the heat that would be gene...ocess in a carbon capture system. The goal of the ...nd sequestration, or storage (CCS), and thus limit...to the atmosphere by coal-fired power plants. , ...
(Date:11/19/2009)...ical with an unwieldy name: 4-hydroxybutyrate (4-H...date-rape drug. , Now, a team of Ohio and Michi... 4-HB is metabolized by the body. "This is new and...rofessor and chair of biological sciences at Michi...esearch team. "It may provide new clues on how to...
Breaking Biology News(10 mins):Flax and yellow flowers can produce bioethanol 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Researchers begin to decipher metabolism of sexual assault drug 2The ends of mRNAs may prevent the beginnings of cancer 9638 1The ends of mRNAs may prevent the beginnings of cancer 9638 2Disrupting a destructive duo 3A U of T Mississauga researchers inhibit cancer proteins 9634 1Disrupting a destructive duo 3A U of T Mississauga researchers inhibit cancer proteins 9634 2Nostrils Compete to Relay Key Fragrance 54963 1Nostrils Compete to Relay Key Fragrance 54963 2
...considered the one and only way biological traits ...sms. , Not anymore. , Increasingly, biologists ...ring the life of an organism can sometimes be pass... inheritance. An article forthcoming in the July i...er 100 well-documented cases of epigenetic inherit...
...Project, which involves the Overseas Development G... to encourage sustainable development schemes in d...on, mitigation and conservation benefits, as well ...years an innovative web-based system will be devel...mount of carbon, and other greenhouse gas emission...
...that is black, brittle and freeze-dried (just like...retty impressive feats. Designed by Northwestern U...luted water, easily separate hydrogen from other g...e effective catalyst than the one currently used t...ation might be a mouthful, but it is also a widely...
Other Biology News:100 reasons to change the way we think about genetics 2100 reasons to change the way we think about genetics 3Carbon measuring system to help mitigate climate change 2Carbon measuring system to help mitigate climate change 3One sponge-like material, three different applications 2One sponge-like material, three different applications 3
(Date:11/19/2009)... -- Danish Prince Joachim inaugurated the DONG Ene...borg, Denmark, on Wednesday, November 18. The faci...eneration ethanol demonstration biorefineries. Gen...s innovative process for converting straw to fuel.... market with commercial enzymes for converting cel...
(Date:11/19/2009)...irstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), ann... to its shareholders, discussing the Company,s acq...euticals Holdings, Inc. (CHBP), an integrated bio-...lic of China. The merger gives NeoStem a controlli...Ltd., CHBP,s primary operating subsidiary and a pr...
(Date:11/19/2009)...- Aegera Therapeutics Inc. announced today the dos...study of AEG35156, a targeted antisense therapeuti...ndications. ,, The study, entitled "An Open-Lab...tor of Apoptosis (XIAP) Antisense AEG35156 Given i...icin in AML Following Failure of a Single Standard...
(Date:11/19/2009)...er 19 AFFiRiS AG will focus its,Al... at an unexpectedly early,stage of development: th...Phase II clinical trial early in 2010. This decisi...on of two Phase I trials with the candidates,AD01 ...he first interim,analysis of the secondary endpoin...
Breaking Biology Technology:DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
... 12 /PRNewswire-FirstCall/ - Neptune Technologies ...V.NTB), "Neptune" today,announced its results for ...e,s Highlights:, - First Quarter ended August 3...5,000 compared to $1,552,000, for the fir...., - EBITDA increased by 10% to $332,000 co...
... on Global List for Fifth Consecutive Year, CAMBR... GENZ ) announced today that scientists have agai...king the reputations of biotechnology and,pharmace...nearly 500,companies. Over the past five years Gen...ll biotechnology and pharmaceutical companies. Gen...
...fforts to Expand Market and Prepare for Zingo Laun...y Donahue Promoted To Senior Vice President, Marke...To Vice President, Marketing - - Addit...s to be Presented at Investor Briefing Today at 12... -, SOUTH SAN FRANCISCO, Calif., Oct. 12 Anesiva...
Other Biology Technology:Neptune Technologies & Bioressources Inc. Reports First Quarter Results and Business Update 2Neptune Technologies & Bioressources Inc. Reports First Quarter Results and Business Update 3Genzyme Recognized by Scientists as a Top Employer 2Genzyme Recognized by Scientists as a Top Employer 3Genzyme Recognized by Scientists as a Top Employer 4Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 2Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 3Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 4Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 5Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 6Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 7
Rat Anti-Human MFRP Monoclonal Antibody, Unconjugated, Clone 291218 from R&D Systems
Rabbit Anti-HOXD3 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Mouse Anti-Human Complement Component C5a Monoclonal Antibody, Unconjugated, Clone 295003 from R&D Systems
Goat Anti-Human CXCL14 / BRAK Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: